A new real-world study confirms that implantable cardioverter defibrillators (ICDs) save lives.
Over 20 years ago, the landmark MADIT II trial showed that ICDs can provide life-saving therapy for heart failure...
News We’re Watching: ICD Trial Success, EOFlow Restraining Order, Hamilton Ventilator Recall
This week, Medtronic presented data from two new real-world trials confirming that ICDs save lives; a restraining order was issued against EOFlow in Insulet’s intellectual property case; and Polarean’s MRI gas XENOVIEW received a new Medicare reimbursement code.
More from Business
• By
An interactive look at medtech and diagnostics deals made during June 2025. Data courtesy of Biomedtracker.
• By
Paul Campbell, chief regulatory officer at HealthAI, emphasizes existing regulations for AI in healthcare should not be overlooked as new regulations are developed.
• By
CEO Alexandre Chau told Medtech Insight that the Middle East and Africa presented the ideal mix of market potential, physician training opportunities, and regulatory readiness when the company was considering expansion markets beyond Europe and the US.
• By
A recent approval from the US FDA allowing Boston Scientific to broaden its labeling for its pulse field ablation system means more patients with one type of AFib will have access to a promising new treatment.
More from Medtech Insight
• By
A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.
• By
An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.
• By
The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.